These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28699244)

  • 1. Biophysical characterization of layer-by-layer synthesis of aptamer-drug microparticles for enhanced cell targeting.
    Tan KX; Danquah MK; Sidhu A; Lau SY; Ongkudon CM
    Biotechnol Prog; 2018 Jan; 34(1):249-261. PubMed ID: 28699244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding Characterization of Aptamer-Drug Layered Microformulations and In Vitro Release Assessment.
    Tan KX; Danquah MK; Pan S; Yon LS
    J Pharm Sci; 2019 Sep; 108(9):2934-2941. PubMed ID: 31002808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Process evaluation and in vitro selectivity analysis of aptamer-drug polymeric formulation for targeted pharmaceutical delivery.
    Tan KX; Lau SY; Danquah MK
    Biomed Pharmacother; 2018 May; 101():996-1002. PubMed ID: 29635910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-Mediated Polymeric Vehicles for Enhanced Cell-Targeted Drug Delivery.
    Tan KX; Danquah MK; Sidhu A; Yon LS; Ongkudon CM
    Curr Drug Targets; 2018 Feb; 19(3):248-258. PubMed ID: 27321771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery.
    Xu L; He XY; Liu BY; Xu C; Ai SL; Zhuo RX; Cheng SX
    Colloids Surf B Biointerfaces; 2018 Nov; 171():24-30. PubMed ID: 30005287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards targeted cancer therapy: Aptamer or oncolytic virus?
    Tan KX; Danquah MK; Sidhu A; Ongkudon CM; Lau SY
    Eur J Pharm Sci; 2017 Jan; 96():8-19. PubMed ID: 27593990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
    J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric nanoparticles for siRNA delivery and gene silencing.
    Patil Y; Panyam J
    Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery.
    Wang Z; Li Z; Zhang D; Miao L; Huang G
    Drug Deliv; 2015 Jan; 22(1):79-85. PubMed ID: 24401038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation on novel chitosan nanoparticle-aptamer complexes targeting TGF-β receptor II.
    Chen X; Zhu X; Li L; Xian G; Wang W; Ma D; Xie L
    Int J Pharm; 2013 Nov; 456(2):499-507. PubMed ID: 23999222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamers in targeted nanotherapy.
    Mathew A; Maekawa T; Sakthikumar D
    Curr Top Med Chem; 2015; 15(12):1102-14. PubMed ID: 25866269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
    Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity.
    Zhao L; Zhou Y; Gao Y; Ma S; Zhang C; Li J; Wang D; Li X; Li C; Liu Y; Li X
    Int J Pharm; 2015 Apr; 483(1-2):180-7. PubMed ID: 25681723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
    Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H
    Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.
    Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S
    Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
    Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
    Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
    Li FQ; Su H; Wang J; Liu JY; Zhu QG; Fei YB; Pan YH; Hu JH
    Int J Pharm; 2008 Feb; 349(1-2):274-82. PubMed ID: 17870261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.